Literature DB >> 30576701

Age and liver transplantation.

François Durand1, Josh Levitsky2, François Cauchy3, Hélène Gilgenkrantz4, Olivier Soubrane5, Claire Francoz6.   

Abstract

The average age of liver transplant donors and recipients has increased over the years. Independent of the cause of liver disease, older candidates have more comorbidities, higher waitlist mortality and higher post-transplant mortality than younger patients. However, transplant benefit may be similar in older and younger recipients, provided older recipients are carefully selected. The cohort of elderly patients transplanted decades ago is also increasingly raising issues concerning long-term exposure to immunosuppression and aging of the transplanted liver. Excellent results can be achieved with elderly donors and there is virtually no upper age limit for donors after brain death liver transplantation. The issue is how to optimise selection, procurement and matching to ensure good results with elderly donors. The impact of old donor age is more pronounced in younger recipients and patients with a high model for end-stage liver disease score. Age matching between the donor and the recipient should be incorporated into allocation policies with a multistep approach. However, age matching may vary depending on the objectives of different allocation policies. In addition, age matching must be revisited in the era of direct-acting antivirals. More restrictive limits have been adopted in donation after circulatory death. Perfusion machines which are currently under investigation may help expand these limits. In living donor liver transplantation, donor age limit is essentially guided by morbidity related to procurement. In this review we summarise changing trends in recipient and donor age. We discuss the implications of older age donors and recipients. We also consider different options for age matching in liver transplantation that could improve outcomes.
Copyright © 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age; Deceased donor transplantation; Donation after circulatory death; Liver transplantation; Living donor liver transplantation; Waiting list mortality

Year:  2018        PMID: 30576701     DOI: 10.1016/j.jhep.2018.12.009

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  33 in total

1.  Differential Impact of Age Among Liver Transplant Candidates With and Without Hepatocellular Carcinoma.

Authors:  Giuseppe Cullaro; Jessica B Rubin; Neil Mehta; Jennifer C Lai
Journal:  Liver Transpl       Date:  2019-11-20       Impact factor: 5.799

2.  A panel of biomarkers in the prediction for early allograft dysfunction and mortality after living donor liver transplantation.

Authors:  Hsin-I Tsai; Chi-Jen Lo; Chao-Wei Lee; Jr-Rung Lin; Wei-Chen Lee; Hung-Yao Ho; Chia-Yi Tsai; Mei-Ling Cheng; Huang-Ping Yu
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

3.  [Effects of Panax notoginseng saponins on liver graft rejection in rats and the mechanisms].

Authors:  Xianbing Zhang; Xun Li; Ping Xiong; Chuanchao Yi; Xi Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-04-30

4.  Clinical Practice Guidelines for Liver Transplantation in Saudi Arabia.

Authors:  Faisal A Abaalkhail; Mohammed I Al Sebayel; Mohammed A Shagrani; Wael A O'Hali; Nasser M Almasri; Abduljaleel A Alalwan; Mohammed Y Alghamdi; Hamad Al-Bahili; Mohammed S AlQahtani; Saleh I Alabbad; Waleed K Al-Hamoudi; Saleh A Alqahtani
Journal:  Saudi Med J       Date:  2021-09       Impact factor: 1.422

5.  The liver transplant risk score prognosticates the outcomes of liver transplant recipients at listing.

Authors:  Christof Kaltenmeier; Dana Jorgensen; Stalin Dharmayan; Subhashini Ayloo; Vikrant Rachakonda; David A Geller; Samer Tohme; Michele Molinari
Journal:  HPB (Oxford)       Date:  2020-11-11       Impact factor: 3.647

6.  Liver Transplant Recipient, Caregiver, and Provider Perceptions of Cardiovascular Disease and Related Risk Factors After Transplant.

Authors:  Lisa B VanWagner; Elisa Gordon; Lindsay Adamski; Megan Kosirog; Amna Daud; Daniel J Finn; Donald M Lloyd-Jones; Jane L Holl
Journal:  Liver Transpl       Date:  2021-05       Impact factor: 5.799

7.  Causes of Death and Survival in Alcoholic Cirrhosis Patients Undergoing Liver Transplantation: Influence of the Patient's Clinical Variables and Transplant Outcome Complications.

Authors:  J M Bolarín; M D Pérez-Cárceles; J P Hernández Del Rincón; A Luna; A Minguela; M Muro; I Legaz
Journal:  Diagnostics (Basel)       Date:  2021-05-27

8.  Early Allograft Dysfunction Increases Hospital Associated Costs After Liver Transplantation-A Propensity Score-Matched Analysis.

Authors:  Simon Moosburner; Igor M Sauer; Frank Förster; Thomas Winklmann; Joseph Maria George Vernon Gassner; Paul V Ritschl; Robert Öllinger; Johann Pratschke; Nathanael Raschzok
Journal:  Hepatol Commun       Date:  2020-12-05

9.  Patients' Experiences of Life Challenges After Liver Transplantation: A Qualitative Study.

Authors:  Mohammad Taher; Mohssen Nassiri Toossi; Ali Jafarian; Arezoo Rasti; Nahid Dehghan Nayeri
Journal:  J Patient Exp       Date:  2021-02-26

Review 10.  Impact of Aging on Liver Cells and Liver Disease: Focus on the Biliary and Vascular Compartments.

Authors:  Leonardo Baiocchi; Shannon Glaser; Heather Francis; Lindsey Kennedy; Eric Felli; Gianfranco Alpini; Jordi Gracia-Sancho
Journal:  Hepatol Commun       Date:  2021-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.